GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032
Overview
The GSA and Benelux Point-Of-Care-Testing (POCT) Market is expected to reach a 21.63 USD Billion by 2032 and is projected to grow at a CAGR of 9.31% from 2025 to 2032.
Revenue, 2024 (USD Billion)
10.65
Forecast, 2032 (USD Billion)
21.63
CAGR, 2024 - 2032
9.31%
Report Coverage
Europe
GSA and Benelux Point-Of-Care-Testing (POCT) Market 2018-2032 USD Billion
GSA and Benelux Point-Of-Care-Testing (POCT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 10.65 USD Billion
- Projected Market Size (2032): 21.63 USD Billion
- CAGR (2025-2032): 9.31%
Key Findings of GSA and Benelux Point-Of-Care-Testing (POCT) Market
- The GSA and Benelux Point-Of-Care-Testing (POCT) Market was valued at 10.65 USD Billion in 2024.
- The GSA and Benelux Point-Of-Care-Testing (POCT) Market is likely to grow at a CAGR of 9.31% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment OTC Testing in Prescription Mode Segment accounted for the largest share of the market with a revenue of 5.92 USD Billion
- The fastest growing segment Lateral Flow Assays/Immunochromatography Tests in Platform Segment grew Fastest with a CAGR of 10.28% during the forecast period from 2024 to 2032.
GSA and Benelux Point-Of-Care-Testing (POCT) Market Scope
GSA and Benelux Point-Of-Care-Testing (POCT) Market Segmentation & Scope
Product Type
- Others
- Fecal Occult Testing Products
- Tumor/Cancer Marker Testing Products
- Cholesterol Testing Products
- Urinalysis Testing Products
- Drugs-Of-Abuse (DOA) Testing Products
- Coagulation Monitoring Products
- Hematology Testing Products
- Pregnancy and Fertility Testing Products
- Cardiometabolic Monitoring Products
- Infectious Disease Testing Products
- Glucose Monitoring Products
Platform
- Others
- Hematology
- Microfluidics
- Clinical Chemistry Assays
- Molecular Diagnostics
- Dipsticks
- Immunoassays
- Lateral Flow Assays/Immunochromatography Tests
Distribution Channel
- Others
- Online Sales
- Retail Sales
- Direct Tender
End User
- Others
- Elderly Care Centers
- Ambulatory Surgery Centers
- Pathology Labs
- Diagnostic Centers
- Laboratories
- Clinics
- Home Care
- Hospitals
Application
- Whole Blood Analysis
- Others
- Non- Invasive PCO2 Monitoring
- Blood Transfusion
- Non- Invasive SpO2 Monitoring
- Hematology
- Coagulation
- Cardiac Monitoring
- Vital Sign Monitoring
- Infectious Diseases
- Blood Glucose
Prescription Mode
- Prescription-Based Testing
- OTC Testing
GSA and Benelux Point-Of-Care-Testing (POCT) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2024 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 10.65 USD Billion |
| Market Value in 2032 | 21.63 USD Billion |
| CAGR (2025-2032) | 9.31% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product Type,Platform,Distribution Channel,End User,Application ,Prescription Mode |
Regional Insights:
-
Leading Market (2024-2032): Europe, leading in terms of revenue 10.65 USD Billion in 2024
- Key Country: RoE, leading in terms of revenue with value of 6,128.70 USD Million in 2024.
Segments and Scope
-
GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032, By Product Type
- Glucose Monitoring Products is the largest segment in GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032 with a revenue of 3.74 USD Billion in the year 2024.
- Glucose Monitoring Products is the Fastest growing segment in GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032 with a Growth rate of 10.04 % in forecast period 2025-2032.
-
GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032, By Platform
- Lateral Flow Assays/Immunochromatography Tests is the largest segment in GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032 with a revenue of 4.08 USD Billion in the year 2024.
- Lateral Flow Assays/Immunochromatography Tests is the Fastest growing segment in GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032 with a Growth rate of 10.28 % in forecast period 2025-2032.
-
GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032 with a revenue of 4.89 USD Billion in the year 2024.
- Online Sales is the Fastest growing segment in GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032 with a Growth rate of 8.81 % in forecast period 2025-2032.
-
GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032, By End User
- Hospitals is the largest segment in GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032 with a revenue of 3.66 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032 with a Growth rate of 9.74 % in forecast period 2025-2032.
-
GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032, By Application
- Blood Glucose is the largest segment in GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032 with a revenue of 3.74 USD Billion in the year 2024.
- Blood Glucose is the Fastest growing segment in GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032 with a Growth rate of 10.04 % in forecast period 2025-2032.
-
GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032, By Prescription Mode
- OTC Testing is the largest segment in GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032 with a revenue of 5.92 USD Billion in the year 2024.
- OTC Testing is the Fastest growing segment in GSA and Benelux Point-Of-Care-Testing (POCT) Market to 2032 with a Growth rate of 9.45 % in forecast period 2025-2032.
GSA and Benelux Point-Of-Care-Testing (POCT) Market Company Share Analysis
| Company Name |
|
||
| BIOMÉRIEUX | |||
| Bio-Rad Laboratories, Inc. | |||
| Danaher | |||
| F. Hoffmann-La Roche Ltd. | |||
| Siemens Healthineers AG | |||
GSA and Benelux Point-Of-Care-Testing (POCT) Market Geographical Sales Distribution, 2018-2032 USD Billion
GSA and Benelux Point-Of-Care-Testing (POCT) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The GSA and Benelux Point-Of-Care-Testing (POCT) Market is segmented based on Segmentation Product Type,Platform,Distribution Channel,End User,Application ,Prescription Mode.
GSA and Benelux Point-Of-Care-Testing (POCT) Market was valued at USD 10.65(Revenue in USD Billion) in 2024.
GSA and Benelux Point-Of-Care-Testing (POCT) Market is projected to grow at a CAGR of 9.31% during the forecast period of 2024 to 2032.
The OTC Testing segment is expected to dominate the GSA and Benelux Point-Of-Care-Testing (POCT) Market, holding a largest market share of 5.92 USD Billion in 2024
Coming Soon....
GSA and Benelux Point-Of-Care-Testing (POCT) Market Scope
GSA and Benelux Point-Of-Care-Testing (POCT) Market Segmentation & Scope
Product Type
- Others
- Fecal Occult Testing Products
- Tumor/Cancer Marker Testing Products
- Cholesterol Testing Products
- Urinalysis Testing Products
- Drugs-Of-Abuse (DOA) Testing Products
- Coagulation Monitoring Products
- Hematology Testing Products
- Pregnancy and Fertility Testing Products
- Cardiometabolic Monitoring Products
- Infectious Disease Testing Products
- Glucose Monitoring Products
Platform
- Others
- Hematology
- Microfluidics
- Clinical Chemistry Assays
- Molecular Diagnostics
- Dipsticks
- Immunoassays
- Lateral Flow Assays/Immunochromatography Tests
Distribution Channel
- Others
- Online Sales
- Retail Sales
- Direct Tender
End User
- Others
- Elderly Care Centers
- Ambulatory Surgery Centers
- Pathology Labs
- Diagnostic Centers
- Laboratories
- Clinics
- Home Care
- Hospitals
Application
- Whole Blood Analysis
- Others
- Non- Invasive PCO2 Monitoring
- Blood Transfusion
- Non- Invasive SpO2 Monitoring
- Hematology
- Coagulation
- Cardiac Monitoring
- Vital Sign Monitoring
- Infectious Diseases
- Blood Glucose
Prescription Mode
- Prescription-Based Testing
- OTC Testing
Frequently Asked Questions
The GSA and Benelux Point-Of-Care-Testing (POCT) Market is segmented based on Segmentation Product Type,Platform,Distribution Channel,End User,Application ,Prescription Mode.
GSA and Benelux Point-Of-Care-Testing (POCT) Market was valued at USD 10.65(Revenue in USD Billion) in 2024.
GSA and Benelux Point-Of-Care-Testing (POCT) Market is projected to grow at a CAGR of 9.31% during the forecast period of 2024 to 2032.
The estimated market value of the GSA and Benelux Point-Of-Care-Testing (POCT) Market for final year is USD 21.63 (USD Billion).
GSA and Benelux Point-Of-Care-Testing (POCT) Market Company Profiling
Frequently Asked Questions
The GSA and Benelux Point-Of-Care-Testing (POCT) Market is segmented based on Segmentation Product Type,Platform,Distribution Channel,End User,Application ,Prescription Mode.
GSA and Benelux Point-Of-Care-Testing (POCT) Market was valued at USD 10.65(Revenue in USD Billion) in 2024.
GSA and Benelux Point-Of-Care-Testing (POCT) Market is projected to grow at a CAGR of 9.31% during the forecast period of 2024 to 2032.
The estimated market value of the GSA and Benelux Point-Of-Care-Testing (POCT) Market for final year is USD 21.63 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.